Provider QP63-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Ryplazim® (plasminogen, human-tvmh) Read More
Provider QP55-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2022 Read More
Provider QP54-20 MHCP Pharmacy Benefit Update — Pharmacy Benefit Exclusion for Nexplanon® and Trodelvy™ Read More
Provider QP57-20 Commercial Pharmacy Benefit Update: Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs Read More
Provider QP56-20 U.S. Department of Health and Human Services Announced Additional Opportunity for Funding Read More
Provider QP49-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema (HAE) Read More
Provider QP48-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Obeticholic acid Read More
